Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: Protocol-Specified Final Analysis from KEYNOTE-189
作者单位Medical Oncology, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain[1]Oncology, Sanford Health, Sioux Falls, USA[2]Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria[3]Thoracic Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USA[4]Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo[5]Medical Oncology Department, Vall d'Hebron University, Vall d'Hebron Institute of Oncology (VHIO),Barcelona, Spain[6]Centre Integré de Cancérologie de la Montérégie, H?pital Charles-Le Moyne, Greenfield Park, Canada[7]Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz,Ⅱs-FJD, Madrid, Spain[8]Sunnybrook Health Sciences Centre,Toronto, Canada[9]Thoraxklinik, Heidelberg, Germany[10]Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel[11]Lungen Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany[12]Department of Medical Oncology, Westmead Hospital and University of Sydney, Sydney, Australia[13]Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA[14]Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia[15]Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan[16]Merck & Co., Inc., Kenilworth, USA[17]Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;University of Chicago Medicine & Biological Sciences, Knapp Center for Biomedical Discovery, Chicago, USA[18]同济大学附属上海市肺科医院肿瘤科,上海 200433[19]
换一批
换一批
